Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh

About this episode

Dr. Kevin Folta discusses conditionally active biologics and their potential to revolutionize cancer treatment with Dr. Neela Patel and Dr. Diane Hollenbaugh.

In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.

People in this episode

Host: Kevin Folta

Guests: Dr Neela Patel, Dr Diane Hollenbaugh

Topics covered

• conditionally active biologics
• immuno-oncology
• cancer treatment
• drug development
• targeted therapies

Keywords

• Bonum Therapeutics
• market landscape
• patient outcomes

More episodes of Talking Biotech with Dr. Kevin Folta

• Milk Proteins without the Dairy - Adam Tarshis and Dr. Cory Tobin · June 9, 2026 · 48 min
• New Technology in Severe Burn Care - Dr. Katie Bush · June 1, 2026 · 29 min
• Molecular Residue Cancer Detection - Dr. Nate Montgomery · May 25, 2026 · 37 min
• Strategies in Combating Chronic Kidney Disease - Dr. Salvatore Viscomi · May 17, 2026 · 38 min
• AI and the Future of Healthcare -- Dr. Emilia Javorsky · May 8, 2026 · 39 min
• The First Environmental GE Organism Release - almost! Dr. Steven Lindow · April 28, 2026 · 26 min